E-mail: simkoma3@fnhk.cz
Odborné práce publikované na Linkos.cz
Přehled odborných textů publikovaných autorem na portálu Linkos.cz. Jsou zde uvedeny knihy a brožury, články v Klinické onkologii, tuzemská abstrakta z databáze abstrakt a další texty. Rejstřík není v žádném případě úplným autorským rejstříkem, protože jsou zde uvedeny pouze texty zveřejněné na portálu Linkos.cz.
Publikovaná abstrakta
- COMPLEX ACTIVATION OF ANGIOGENIC SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA: EVIDENCE FROM CIRCULATING ANGIOGENIC CYTOKINES
- EFFICACY AND SAFETY OF RITUXIMAB AND HIGH-DOSE DEXAMETHASONE (R-DEX) IN THE TREATMENT OF RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA
- Exprese fibroblastového růstového faktoru 2 u pacientů s chronickou lymfocytární leukemií
- LOW-DOSE FCR IN ELDERLY/COMORBID PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA (CLL/SLL): UPDATED RESULTS OF PROJECT Q-LITE BY CZECH CLL STUDY GROUP
- Low-Dose FCR Is a Safe and Effective Treatment Option for Elderly/Comorbid Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Updated Results of Project Q-Lite By Czech CLL Study Group
- Observational Study Alternating R-CHOP21 and R-Cytarabine (3+3 Cycles) for Patients with Newly Diagnosed Mantle Cell Lymphoma Not Eligible for High-Dose Therapy: A Czech Lymphoma Study Group Trial Preliminary Results
- PROCOAGULANT ACTIVITY OF CIRCULATING MICROPARTICLES IN HEMODIALYSIS PATIENTS
- Rezistence na kyselinu acetylosalicylovou u hemodialyzovaných pacientů
- Rituximab and High-Dose Dexamethasone (R-dex) Is Effective In The Treatment Of Relapsed/Refractory Chronic Lymphocytic Leukemia
- RITUXIMAB IN COMBINATION WITH HIGH-DOSE DEXAMETHASONE: AN EFFECTIVE TREATMENT OPTION FOR PATIENTS WITH RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA
- Rituximab In Combination with High-Dose Dexamethasone: An Effective Treatment Option for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia
- RITUXIMAB INFUSION-RELATED TOXICITY IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA
- SPLENECTOMY IN THE TPO MIMETIC ERA – STILL REASONABLE APPROACH?
- THE ROLE OF IMAGING METHODS IN CHRONIC LYMPHOCYTIC LEUKEMIA: SIGNIFICANT INTERNAL LYMPHADENOPATHY IS FREQUENT AND ASSOCIATED WITH SHORTER OVERALL SURVIVAL
- VENOUS THROMBEMBOLISM: A FREQUENT COMPLICATION IN CHRONIC LYMPHOCYTIC LEUKEMIA
